RE:RE:RE:Merck USA (MSD) acquires Phase 2 blood cancer co - US$1.35BNoteable wrote: With Merck USA paying up big for Phase 2 single indication blood cancer - this confirms that Big Pharma is in significant need of innovative cancer drugs to face off the challenge of a looming patent cliff by 2025 and every new cancer drug in development is on the table for their immediate acquisition, more particularly immuno-oncology platform therapy drugs like ONCY'S pelareorep which can be used in multiple cancers with multiple existing I/O agents like immune checkpoint inhibitors for example.
Without Parsons and Rigby in house I would be completly out! Something positive in the coming weeks is clearly possible. I'm Not surprise to see the price going down. Some are taking profit, maybe a little bit of manipulation of course... Manipulation could be very high particularly when negociations are in full force! We will see...